Provided by Tiger Trade Technology Pte. Ltd.

iShares U.S. Pharmaceuticals ETF

105.00
+1.020.98%
Volume:237.31K
Turnover:24.94M
Market Cap:1.71B
PE:9.78
High:106.23
Open:104.88
Low:104.57
Close:103.98
52wk High:108.66
52wk Low:69.02
Shares:16.30M
Float Shares:16.30M
Volume Ratio:1.27
T/O Rate:1.46%
Dividend:1.47
Dividend Rate:1.40%
EPS(TTM):10.74
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Moderna Stock (MRNA) Rises 12.5% Today Following Phase 3 mRNA Cancer Vaccine Win with Merck

TIPRANKS
·
Aug 26

Confirm That We Have Ended Our Partnership with Cellares. - Bristol Myers Spokesperson

THOMSON REUTERS
·
Aug 25

Bristol Myers Spokesperson: Determined Cellares-Partnered Cell Shuttle System Could not Meet Necessary Requirements to Make Commercial Breyanzi

THOMSON REUTERS
·
Aug 25

FDA Greenlights Roche and Eli Lilly's Blood-Based Alzheimer's Test, Setting a Single Threshold to Rule Both In and Out Amyloid Pathology

Deep News
·
Aug 25

Moderna Inc Stock (MRNA) Moved Up by 10.02% on Aug 25: Drivers Behind the Movement

TradingKey
·
Aug 25

Merck Price Target Raised to $170.00/Share from $145.00 by Argus Research

Dow Jones
·
Aug 25

Stick with Value Stocks Until Everyone Starts Talking About Them - and as of Now They're Still Under the Radar, This Wall Street Firm Says

Dow Jones
·
Aug 25

Merck & Company (MRK) Gets a Buy from Scotiabank

TIPRANKS
·
Aug 25

Merck price target raised to $170 from $145 at Argus

TIPRANKS
·
Aug 25

Parabilis Medicines Appoints Former J&J Oncology Executive Craig Tendler to Board

Reuters
·
Aug 25

Merck price target raised to $180 from $155 at Wolfe Research

TIPRANKS
·
Aug 25

Analysts Offer Insights on Healthcare Companies: Boston Scientific (BSX) and Eli Lilly & Co (LLY)

TIPRANKS
·
Aug 25

Merck (MRK) Stock May Be 35% Undervalued After Cancer Vaccine Data

Simply Wall St.
·
Aug 25

US FDA Expands Approval for J&J's Drug for Rare Blood Disorder

Reuters
·
Aug 25

FDA Approves J&J Imaavy for Warm Autoimmune Hemolytic Anemia Treatment

Reuters
·
Aug 25

FDA Approves Imaavy® as First-Ever Treatment for Warm Autoimmune Hemolytic Anemia (Waiha), Representing a Landmark Advancement for Patients

THOMSON REUTERS
·
Aug 25

Eli Lilly Stock (LLY) in Focus as Hedge Fund Titan Ken Griffin Quadruples Position

TIPRANKS
·
Aug 25

Sector Update: Healthcare

MT Newswires Live
·
Aug 25

Eli Lilly’s New Obesity Drug LY3549492 Moves Forward With Completed Phase 1 Trial

TIPRANKS
·
Aug 25

Eli Lilly (LLY) On Foundayo Launch And Higher Outlook Faces A Rich Valuation

Simply Wall St.
·
Aug 24